Cassava Sciences, Inc. (SAVA)

Cassava Sciences Market Cap

Cassava Sciences has a market cap or net worth of $848.94 million as of April 19, 2024. Its market cap has decreased by -11.17% in one year.

• Market Cap: 848.94M
• Enterprise Value: 727.81M
• 1-Year Change: -11.17%
• Ranking: #2468
• Category: Small-Cap
• Stock Price: $19.64

Market Cap Chart

Since July 14, 2000, Cassava Sciences's market cap has increased from $565.10M to $848.94M, an increase of 50.23%. That is a compound annual growth rate of 1.73%.

Market Cap History

Date	Market Cap	% Change
Apr 18, 2024	915.90M	-0.38%
Apr 17, 2024	919.40M	1.14%
Apr 16, 2024	909.00M	5.10%
Apr 15, 2024	864.90M	-12.05%
Apr 12, 2024	983.40M	-12.87%
Apr 11, 2024	1.13B	6.53%
Apr 10, 2024	1.06B	-3.51%
Apr 9, 2024	1.10B	7.76%
Apr 8, 2024	1.02B	10.61%
Apr 5, 2024	921.10M	4.04%
Apr 4, 2024	885.30M	-0.48%
Apr 3, 2024	889.60M	4.41%
Apr 2, 2024	852.00M	-2.85%
Apr 1, 2024	877.00M	-
Mar 28, 2024	877.00M	-0.65%
Mar 27, 2024	882.70M	3.60%
Mar 26, 2024	852.00M	0.06%
Mar 25, 2024	851.50M	-0.56%
Mar 22, 2024	856.30M	-6.47%
Mar 21, 2024	915.50M	-3.60%
Mar 20, 2024	949.70M	-0.08%
Mar 19, 2024	950.50M	3.34%
Mar 18, 2024	919.80M	-0.05%
Mar 15, 2024	920.30M	2.91%
Mar 14, 2024	894.30M	0.19%

View and export this data all the way back to 2000. Sign Up Today.

Related Stocks

Company	Market Cap
Abivax	950.68M
Innoviva	928.81M
BioCryst Pharmaceuticals	927.68M
Bicycle Therapeutics	923.22M
Cronos Group	918.93M
MiMedx Group	905.26M
Zentalis Pharmaceuticals	889.84M
Simulations Plus	887.53M